170
Views
6
CrossRef citations to date
0
Altmetric
Research Article

A 26-week repeated-dose toxicity study of allisartan isoproxil in Sprague-Dawley rats

, , , , , , , & show all
Pages 443-450 | Received 10 Aug 2012, Accepted 12 Dec 2012, Published online: 27 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chunfang Xu, Ziying Zhao, Wang Yuan, Zhao Fengping, Yan Zhiqiang & Zhang Xiaoqin. (2022) Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats. Clinical and Experimental Hypertension 44:3, pages 199-207.
Read now

Articles from other publishers (5)

Ruibin Li, Li Li, Jidong Zhang, Dong Wang, Xiaoran Cui, Long Bai, Lei Zhao & Xiaohong Yang. (2023) Alleviation of renal injury in rabbits by allisartan. Journal of Investigative Medicine 71:2, pages 92-100.
Crossref
Ruibin Li, Li Li, Jidong Zhang, Dong Wang, Xiaoran Cui, Long Bai, Lei Zhao & Xiaohong Yang. (2023) Alleviation of renal injury in rabbits by allisartan. Journal of Investigative Medicine 71:2, pages 92-100.
Crossref
Wu Yi, Peiyuan Yan, Sisi Lin, Rui Hao, Yannan Wang, Jin Yu, Lu Fang, Jingjing Zhu, Di Zhao, Shengjia Tong, Yongkai Si, Tiantian Ye, Zeyu Wu, Zhiquan Qin, Hua Huang, Chongyang Deng, Jingchao Sun & Ying Wang. (2021) Pharmacokinetics and Safety of a Single Dose and Multiple Doses of Allisartan Isoproxil, an Angiotensin II Receptor Blocker, in Healthy Chinese People. Clinical Pharmacology in Drug Development 11:1, pages 43-50.
Crossref
Qi-sheng Ling, Sai-long Zhang, Jia-sheng Tian, Ming-he Cheng, Ai-jun Liu, Feng-hua Fu, Jian-guo Liu & Chao-yu Miao. (2021) Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage. Acta Pharmacologica Sinica 42:6, pages 871-884.
Crossref
Yanxian Hou, Jingbo Shao, Qiang Fu, Jingru Li, Jin Sun & Zhonggui He. (2017) Spray-dried nanocrystals for a highly hydrophobic drug: Increased drug loading, enhanced redispersity, and improved oral bioavailability. International Journal of Pharmaceutics 516:1-2, pages 372-379.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.